<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00687336</url>
  </required_header>
  <id_info>
    <org_study_id>CIR2007/058</org_study_id>
    <nct_id>NCT00687336</nct_id>
  </id_info>
  <brief_title>Helicobacter Pylori Empiric Treatment in Ulcer Bleeding</brief_title>
  <acronym>HETUB</acronym>
  <official_title>Phase IV Study Comparing Helicobacter Pylori Empiric Eradication With Test-Guided Treatment in Patients With Peptic Ulcer Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Sabadell</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consorcio Centro de Investigación Biomédica en Red, M.P.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Sabadell</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to compare the effectiveness of empirical Helicobacter pylori
      treatment compared with treatment depending on diagnostic tests for Helicobacter pylori in
      patients with Upper gastrointestinal bleeding due to peptic ulcer. Main hypothesis is that
      empirical treatment will reduce the number of patients lost to follow-up thus improving the
      cure rates of Hp infection.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Anticipated">May 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Helicobacter pylori eradication rate</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Economical evaluation through cost-effectivity study of the empiric erradicator Helicobacter pylori treatment.</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">178</enrollment>
  <condition>Peptic Ulcer Hemorrhage</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Empirical eradication treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eradication treatment according to a diagnostic test (URT, histological test, breath test or serology).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Empirical Hp eradication</intervention_name>
    <description>Empirical Helicobacter pylori treatment initiated immediately after oral intake is resumed</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Standard Hp eradication treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eradication treatment guided by a positive test</intervention_name>
    <description>Eradication treatment given if there is at least one positive diagnostic test (URT, histological test, breath test or serology) for Helicobacter pylori.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Standard Hp treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18.

          -  Informed Consent signed.

          -  Diagnosis of no variceal upper gastrointestinal bleeding secondary to a duodenal
             ulcer, erosive duodenitis or gastric ulcer.

          -  Life expectancy longer than 6 months.

          -  Able to attend further clinical controls.

          -  Absence of the following exclusion criteria.

        Exclusion Criteria:

          -  Previous eradication treatment.

          -  Use of antibiotics 2 weeks prior to inclusion.

          -  Need for Antisecretor treatment that cannot be stopped to perform the breath test.

          -  Pregnancy or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pilar Garcia, Dra.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Sabadell</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xavier Calvet, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital de Sabadell</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pilar Garcia, Dra.</last_name>
    <phone>34-93-723-1010</phone>
    <phone_ext>20101</phone_ext>
    <email>pgarciai@telefonica.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xavier Calvet, Dr.</last_name>
    <phone>34-93-723-1010</phone>
    <phone_ext>20101</phone_ext>
    <email>xcalvet@tauli.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Sabadell, Institut Universitari Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Calam J. Helicobacter pylori. Eur J Clin Invest. 1994 Aug;24(8):501-10. Review.</citation>
    <PMID>7982436</PMID>
  </reference>
  <reference>
    <citation>Lambert JR, Lin SK, Aranda-Michel J. Helicobacter pylori. Scand J Gastroenterol Suppl. 1995;208:33-46. Review.</citation>
    <PMID>7777803</PMID>
  </reference>
  <reference>
    <citation>Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology. 2005 May;128(6):1567-78. Review.</citation>
    <PMID>15887152</PMID>
  </reference>
  <reference>
    <citation>Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther. 1995;9 Suppl 2:59-69. Review.</citation>
    <PMID>8547530</PMID>
  </reference>
  <reference>
    <citation>Gisbert JP, Boixeda D, Aller R, de la Serna C, Sanz E, Martín de Argila C, Abraira V, García Plaza A. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence]. Med Clin (Barc). 1999 Feb 13;112(5):161-5. Spanish.</citation>
    <PMID>10091208</PMID>
  </reference>
  <reference>
    <citation>Gisbert JP, Blanco M, Mateos JM, Fernández-Salazar L, Fernández-Bermejo M, Cantero J, Pajares JM. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci. 1999 Nov;44(11):2295-302.</citation>
    <PMID>10573377</PMID>
  </reference>
  <reference>
    <citation>Soll AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med. 1991 Feb 15;114(4):307-19. Review.</citation>
    <PMID>1987878</PMID>
  </reference>
  <reference>
    <citation>Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med. 1994 Sep 15;331(11):717-27. Review.</citation>
    <PMID>8058080</PMID>
  </reference>
  <reference>
    <citation>Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet. 1987 Nov 14;2(8568):1109-11.</citation>
    <PMID>2890019</PMID>
  </reference>
  <reference>
    <citation>Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24-31;2(8626-8627):1437-42.</citation>
    <PMID>2904568</PMID>
  </reference>
  <reference>
    <citation>Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993 Nov;28(11):939-42.</citation>
    <PMID>8284627</PMID>
  </reference>
  <reference>
    <citation>Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995 Jan;41(1):1-4.</citation>
    <PMID>7698617</PMID>
  </reference>
  <reference>
    <citation>Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study. Am J Gastroenterol. 1998 Jun;93(6):925-7.</citation>
    <PMID>9647020</PMID>
  </reference>
  <reference>
    <citation>Castro-Fernández M, Sánchez-Muñoz D, García-Díaz E, Miralles-Sanchiz J, Vargas-Romero J. Diagnosis of Helicobacter pylori infection in patients with bleeding ulcer disease: rapid urease test and histology. Rev Esp Enferm Dig. 2004 Jun;96(6):395-8; 398-401. English, Spanish.</citation>
    <PMID>15230669</PMID>
  </reference>
  <reference>
    <citation>Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006 Apr;101(4):848-63. Epub 2006 Feb 22. Review.</citation>
    <PMID>16494583</PMID>
  </reference>
  <reference>
    <citation>Gisbert JP, Calvet X, Gomollón F, Monés J; Grupo Conferencia Española de Consenso sobre Helicobacter pylori. [Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]. Med Clin (Barc). 2005 Sep 10;125(8):301-16. Review. Spanish.</citation>
    <PMID>16159556</PMID>
  </reference>
  <reference>
    <citation>Güell M, Artigau E, Esteve V, Sánchez-Delgado J, Junquera F, Calvet X. Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer. Aliment Pharmacol Ther. 2006 Jan 1;23(1):53-9.</citation>
    <PMID>16393280</PMID>
  </reference>
  <reference>
    <citation>García-Altés A, Jovell AJ, Serra-Prat M, Aymerich M. Management of Helicobacter pylori in duodenal ulcer: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2000 Dec;14(12):1631-8.</citation>
    <PMID>11121912</PMID>
  </reference>
  <reference>
    <citation>Sung JJ, Leung WK, Suen R, Leung VK, Chan FK, Ling TK, Lau JY, Lee YT, Ng EK, Cheng AF, Chung SC. One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding. Dig Dis Sci. 1997 Dec;42(12):2524-8.</citation>
    <PMID>9440631</PMID>
  </reference>
  <reference>
    <citation>Gisbert JP, Gonzalez L, de Pedro A, Valbuena M, Prieto B, Llorca I, Briz R, Khorrami S, Garcia-Gravalos R, Pajares JM. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 2001 Jul;36(7):717-24.</citation>
    <PMID>11444470</PMID>
  </reference>
  <reference>
    <citation>Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311-5.</citation>
    <PMID>6145023</PMID>
  </reference>
  <reference>
    <citation>Pellicano R, Peyre S, Leone N, Repici A, De Angelis C, Rizzi R, Rizzetto M, Ponzetto A. The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer. J Clin Gastroenterol. 2001 Mar;32(3):222-4.</citation>
    <PMID>11246348</PMID>
  </reference>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2008</study_first_submitted>
  <study_first_submitted_qc>May 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2008</study_first_posted>
  <last_update_submitted>July 7, 2009</last_update_submitted>
  <last_update_submitted_qc>July 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Xavier Calvet Calvo</name_title>
    <organization>Hospital de Sabadell</organization>
  </responsible_party>
  <keyword>Helicobacter pylori</keyword>
  <keyword>Treatment</keyword>
  <keyword>Upper gastrointestinal bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

